BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33510545
Number of visits today
3587
Number of downloads
16697273
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Song J, Zheng J, Liu X, Dong W, Yang C, Wang D, Ruan X, Zhao Y, Liu L, Wang P, Zhang M, Liu Y. A novel protein encoded by ZCRB1-induced circHEATR5B suppresses aerobic glycolysis of GBM through phosphorylation of JMJD5. J Exp Clin Cancer Res 2022;41:171. [DOI: 10.1186/s13046-022-02374-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Liu G, Qi H, Shen J. JMJD5 inhibits lung cancer progression by regulating glucose metabolism through the p53/TIGAR pathway.. [DOI: 10.21203/rs.3.rs-2504340/v1] [Reference Citation Analysis]
2 Hashemi M, Etemad S, Rezaei S, Ziaolhagh S, Rajabi R, Rahmanian P, Abdi S, Koohpar ZK, Rafiei R, Raei B, Ahmadi F, Salimimoghadam S, Aref AR, Zandieh MA, Entezari M, Taheriazam A, Hushmandi K. Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions. Biomed Pharmacother 2023;158:114204. [PMID: 36916430 DOI: 10.1016/j.biopha.2022.114204] [Reference Citation Analysis]
3 Li H, Jiang Y, Hu J, Xu J, Chen L, Zhang G, Zhao J, Zong S, Guo Z, Li X, Zhao X, Jing Z. The U2AF65/circNCAPG/RREB1 feedback loop promotes malignant phenotypes of glioma stem cells through activating the TGF-β pathway. Cell Death Dis 2023;14:23. [PMID: 36635261 DOI: 10.1038/s41419-023-05556-y] [Reference Citation Analysis]
4 Ma YL, Yang YF, Wang HC, Yang CC, Yan LJ, Ding ZN, Tian BW, Liu H, Xue JS, Han CL, Tan SY, Hong JG, Yan YC, Mao XC, Wang DX, Li T. A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. Front Pharmacol 2023;14:1101749. [PMID: 36909185 DOI: 10.3389/fphar.2023.1101749] [Reference Citation Analysis]
5 Jiang Y, Zhao J, Li R, Liu Y, Zhou L, Wang C, Lv C, Gao L, Cui D. CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. J Exp Clin Cancer Res 2022;41:307. [PMID: 36266731 DOI: 10.1186/s13046-022-02518-8] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345